Reaction
Chronic Hepatitis B reporting signals
As of the last recalculation, Chronic Hepatitis B appears in 310 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is TENOFOVIR DISOPROXIL FUMARATE TABLETS (PRR 267.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tenofovir Disoproxil Fumarate Tablets | 31 | 267.7 | 268.7 |
| Entecavir | 18 | 109.8 | 110.0 |
| Tenofovir Disoproxil Fumarate | 37 | 85.2 | 85.3 |
| Mesna Injection | 9 | 75.3 | 75.4 |
| Mesna | 9 | 73.9 | 74.0 |
| Granisetron Hydrochloride | 9 | 59.6 | 59.6 |
| Granisetron | 9 | 59.3 | 59.4 |
| Lamivudine Oral | 19 | 53.7 | 53.7 |
| Lamivudine | 19 | 43.9 | 43.9 |
| Polatuzumab Vedotin | 3 | 20.8 | 20.8 |